http://www.salem-news.com/articles/january262021/janet-woodcock-fda-commissioner-msp.php
Jan-26-2021
Marianne Skolek-Perez Salem-News.com Investigative Reporter
Will Janet Woodcock, MD be dangerous to America if appointed FDA Commissioner?
Over the years, I have written many articles regarding Janet Woodcock, MD, Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) and her role in the opioid epidemic killing and addicting people in the hundreds of thousands. Links to some of my published articles are shown below.
This week it was announced that Woodcock has been appointed Acting Commissioner of the FDA and was being considered to head the agency that many refer to as "the watchdog for the American people."
The FDA has been relegated to being referred to as "the lapdog for pharma" for many years regarding approval of dangerous drugs even overriding their own Advisory Committee recommendations to "not" approve drugs potentially dangerous to Americans and approving them.
In addition to my concerns over the years with Woodcock's own version of "pay to play" with pharma by approving controversial opioids, there may be even more concerns in her involvement with pharma and currently a new COVID-19 vaccine.
On January 22, Johnson & Johnson (J & J) announced they would have enough vaccines for 100 million Americans by April. This according to Dr. Mark McClellan, a Johnson & Johnson board member and former FDA commissioner.
Yes that is correct – McClellan was former FDA commissioner and is now on J & J's board with another revolutionary COVID-19 vaccine approved by the FDA. Now back to concerns over Woodcock's potentially dangerous appointment as Commissioner of the FDA.
In March 2010, the Pittsburgh Post-Gazette wrote a scathing expose entitled "Drug firm investigated FDA officials". Woodcock was referenced in the article with accusations of possible impropriety by some FDA officials.
One pharmaceutical company was concerned that the FDA was favoring a competitor, Massachusetts-based drug manufacturer Momenta Pharmaceuticals and suspected that Woodcock, the official they blamed for approval delays relating to their drug was somehow allied with Momenta. In April 2009, a complaint was filed with the FDA alleging that Woodcock and Momenta had an improper relationship.
Now while this could have been all smoke and mirrors on October 1, 2020, Johnson & Johnson acquired Momenta Pharmaceuticals and J & J has FDA approval for a new COVID-19 vaccine.
Again, is Janet Woodcock, MD a threat to the American people further than the opioid epidemic, but now with a fast-tracked COVID-19 vaccine and a potential conflict of interest? Hopefully, there will be serious thought given to making Woodcock the Commissioner of the FDA.
I will be continuing to give Woodcock "serious thought" and being certain anyone involved in the approval process making her Commissioner of the FDA – also gives her serious thought.
Sometimes where there is smoke, there is fire.
The link may not show the complete article, so the article is pasted below, referencing Janet Woodcock being investigated as to her ties to Momentum Pharmaceutical, recently acquired by Johnson & Johnson: